How EBNA3C Affects Cyclin D1 in Cancer Cells
Author Information
Author(s): Saha Abhik, Halder Sabyasachi, Upadhyay Santosh K., Lu Jie, Kumar Pankaj, Murakami Masanao, Cai Qiliang, Robertson Erle S.
Primary Institution: Department of Microbiology and Tumor Virology Program, Abramson Comprehensive Cancer Center, University of Pennsylvania Medical School, Philadelphia, Pennsylvania, United States of America
Hypothesis
EBNA3C stabilizes Cyclin D1 and enhances its function, facilitating the G1-S transition in EBV transformed cells.
Conclusion
EBNA3C enhances the stability and activity of Cyclin D1, promoting cell growth and proliferation in EBV-infected B-cells.
Supporting Evidence
- EBNA3C stabilizes Cyclin D1 by inhibiting its poly-ubiquitination.
- EBNA3C enhances the kinase activity of Cyclin D1/CDK6 complex.
- Knockdown of EBNA3C or Cyclin D1 significantly reduces cell growth in EBV transformed lymphoblastoid cell lines.
- EBNA3C promotes nuclear localization of Cyclin D1, bypassing GSK3β-mediated degradation.
Takeaway
EBNA3C helps a protein called Cyclin D1 stay strong and work better, which helps cells grow and divide faster, especially in cancer.
Methodology
The study involved experiments to analyze the interaction between EBNA3C and Cyclin D1, including co-immunoprecipitation, western blotting, and cell proliferation assays.
Limitations
The study primarily focuses on in vitro experiments, which may not fully replicate in vivo conditions.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website